Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Cash (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Change in Cash data on record, last reported at $2.1 million in Q3 2025.

  • For Q3 2025, Change in Cash rose 372.23% year-over-year to $2.1 million; the TTM value through Sep 2025 reached -$4.2 million, down 1822.22%, while the annual FY2024 figure was -$9.9 million, 155.52% down from the prior year.
  • Change in Cash reached $2.1 million in Q3 2025 per UTMD's latest filing, up from -$1.1 million in the prior quarter.
  • Across five years, Change in Cash topped out at $5.9 million in Q1 2023 and bottomed at -$5.5 million in Q4 2024.
  • Average Change in Cash over 5 years is $1.7 million, with a median of $3.3 million recorded in 2022.
  • Peak YoY movement for Change in Cash: soared 956.13% in 2023, then tumbled 223.79% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$3.3 million in 2021, then soared by 265.55% to $5.5 million in 2022, then dropped by 15.92% to $4.7 million in 2023, then plummeted by 217.54% to -$5.5 million in 2024, then soared by 138.13% to $2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $2.1 million in Q3 2025, -$1.1 million in Q2 2025, and $349000.0 in Q1 2025.